4/11
10:32 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
4/11
10:32 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
4/11
06:44 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
4/11
06:44 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
4/11
04:36 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
4/11
04:36 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
4/10
05:12 am
nrix
Rating for NRIX
High
Report
Rating for NRIX
4/10
05:12 am
nrix
Rating for NRIX
High
Report
Rating for NRIX
4/9
08:09 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
High
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
4/9
06:21 am
nrix
Rating for NRIX
High
Report
Rating for NRIX
4/9
06:21 am
nrix
Rating for NRIX
High
Report
Rating for NRIX
4/2
10:05 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
4/2
09:18 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
4/2
09:18 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
3/11
10:17 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
3/11
10:17 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
2/26
11:08 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/26
11:08 am
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/16
01:42 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/16
01:42 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/16
12:36 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/16
12:36 pm
nrix
Rating for NRIX
Low
Report
Rating for NRIX
2/16
08:11 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $31.00 price target on the stock.
2/16
05:32 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX
2/16
05:32 am
nrix
Rating for NRIX
Medium
Report
Rating for NRIX